Skip navigation
  • Sciety Labs 🧪 (Experimental)
  • Search
Sciety application utilities

Microbiology

  • Subscribe to feed (RSS)

Showing page 123 of 252 pages of list content

  • SARS-CoV-2 diverges from other betacoronaviruses in only partially activating the IRE1α/XBP1 ER stress pathway in human lung-derived cells

    This article's authors
    1. Long C. Nguyen
    2. David M. Renner
    3. Diane Silva
    4. Dongbo Yang
    5. Nicholas Parenti
    6. Kaeri M. Medina
    7. Vlad Nicolaescu
    8. Haley Gula
    9. Nir Drayman
    10. Andrea Valdespino
    11. Adil Mohamed
    12. Christopher Dann
    13. Kristin Wannemo
    14. Lydia Robinson-Mailman
    15. Alan Gonzalez
    16. Letícia Stock
    17. Mengrui Cao
    18. Zeyu Qiao
    19. Raymond E. Moellering
    20. Savas Tay
    21. Glenn Randall
    22. Michael F. Beers
    23. Marsha Rich Rosner
    24. Scott A. Oakes
    25. Susan R. Weiss
    This article has 1 evaluations Latest evaluation on Jan 3, 2022 Published on Jun 13, 2022
  • Reduced infectivity but increased immune escape of the new SARS-CoV-2 variant of concern Omicron

    This article's authors
    1. Jie Hu
    2. Pai Peng
    3. Kang Wu
    4. Quan-xin Long
    5. Juan Chen
    6. Kai Wang
    7. Ni Tang
    8. Ai-long Huang
    This article has 1 evaluations Latest evaluation on Dec 30, 2021 Published on Dec 27, 2021
  • The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters

    This article's authors
    1. Rana Abdelnabi
    2. Caroline S. Foo
    3. Xin Zhang
    4. Viktor Lemmens
    5. Piet Maes
    6. Bram Slechten
    7. Joren Raymenants
    8. Emmanuel André
    9. Birgit Weynand
    10. Kai Dallemier
    11. Johan Neyts
    This article has 1 evaluations Latest evaluation on Dec 30, 2021 Published on Dec 26, 2021
  • Rapid selection of P323L in the SARS-CoV-2 polymerase (NSP12) in humans and non-human primate models and confers a large plaque phenotype

    This article's authors
    1. Xiaofeng Dong
    2. Hannah Goldswain
    3. Rebekah Penrice-Randal
    4. Ghada T. Shawli
    5. Tessa Prince
    6. Maia Kavanagh Williamson
    7. Nadine Randle
    8. Benjamin Jones
    9. Francisco J Salguero
    10. Julia A. Tree
    11. Yper Hall
    12. Catherine Hartley
    13. Maximilian Erdmann
    14. James Bazire
    15. Tuksin Jearanaiwitayakul
    16. ISARIC4C investigators
    17. Malcolm G. Semple
    18. Peter J. M. Openshaw
    19. J. Kenneth Baille
    20. Stevan R. Emmett
    21. Paul Digard
    22. David A. Matthews
    23. Lance Turtle
    24. Alistair Darby
    25. Andrew D. Davidson
    26. Miles W. Carroll
    27. Julian A. Hiscox
    This article has 1 evaluations Latest evaluation on Dec 30, 2021 Published on Dec 27, 2021
  • A subset of Memory B-derived antibody repertoire from 3-dose vaccinees is ultrapotent against diverse and highly transmissible SARS-CoV-2 variants, including Omicron

    This article's authors
    1. Kang Wang
    2. Zijing Jia
    3. Linlin Bao
    4. Lei Wang
    5. Lei Cao
    6. Hang Chi
    7. Yaling Hu
    8. Qianqian Li
    9. Yinan Jiang
    10. Qianhui Zhu
    11. Yongqiang Deng
    12. Pan Liu
    13. Nan Wang
    14. Lin Wang
    15. Min Liu
    16. Yurong Li
    17. Boling Zhu
    18. Kaiyue Fan
    19. Wangjun Fu
    20. Peng Yang
    21. Xinran Pei
    22. Zhen Cui
    23. Lili Qin
    24. Pingju Ge
    25. Jiajing Wu
    26. Shuo Liu
    27. Yiding Chen
    28. Weijin Huang
    29. Cheng-Feng Qin
    30. Youchun Wang
    31. Chuan Qin
    32. Xiangxi Wang
    This article has 1 evaluations Latest evaluation on Dec 30, 2021 Published on Jan 3, 2022
  • Homologous or Heterologous Booster of Inactivated Vaccine Reduces SARS-CoV-2 Omicron Variant Escape from Neutralizing Antibodies

    This article's authors
    1. Xun Wang
    2. Xiaoyu Zhao
    3. Jieyu Song
    4. Jing Wu
    5. Yuqi Zhu
    6. Minghui Li
    7. Yuchen Cui
    8. Yanjia Chen
    9. Lulu Yang
    10. Jun Liu
    11. Huanzhang Zhu
    12. Shibo Jiang
    13. Pengfei Wang
    This article has 1 evaluations Latest evaluation on Dec 30, 2021 Published on Dec 27, 2021
  • An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants

    This article's authors
    1. Xiaojing Chi
    2. Xinhui Zhang
    3. Shengnan Pan
    4. Yanying Yu
    5. Tianli Lin
    6. Huarui Duan
    7. Xiuying Liu
    8. Wenfang Chen
    9. Xuehua Yang
    10. Qiang Ding
    11. Jianwei Wang
    12. Wei Yang
    This article has 1 evaluations Latest evaluation on Dec 30, 2021 Published on Dec 25, 2021
  • Convalescence from prototype SARS-CoV-2 protects Syrian hamsters from disease caused by the Omicron variant

    This article's authors
    1. Kathryn A. Ryan
    2. Robert J. Watson
    3. Kevin R. Bewley
    4. Christopher Burton
    5. Oliver Carnell
    6. Breeze E. Cavell
    7. Amy Challis
    8. Naomi S. Coombes
    9. Kirsty Emery
    10. Rachel Fell
    11. Susan A. Fotheringham
    12. Karen E. Gooch
    13. Kathryn Gowan
    14. Alastair Handley
    15. Debbie J. Harris
    16. Richard Humphreys
    17. Rachel Johnson
    18. Daniel Knott
    19. Sian Lister
    20. Daniel Morley
    21. Didier Ngabo
    22. Karen L. Osman
    23. Jemma Paterson
    24. Elizabeth J. Penn
    25. Steven T. Pullan
    26. Kevin S. Richards
    27. Imam Shaik
    28. Sian Summers
    29. Stephen R. Thomas
    30. Thomas Weldon
    31. Nathan R. Wiblin
    32. Richard Vipond
    33. Bassam Hallis
    34. Simon G. P. Funnell
    35. Yper Hall
    This article has 1 evaluations Latest evaluation on Dec 30, 2021 Published on Dec 26, 2021
  • Engineered ACE2 counteracts vaccine-evading SARS-CoV-2 Omicron variant

    This article's authors
    1. Nariko Ikemura
    2. Shunta Taminishi
    3. Tohru Inaba
    4. Takao Arimori
    5. Daisuke Motooka
    6. Kazutaka Katoh
    7. Yuhei Kirita
    8. Yusuke Higuchi
    9. Songling Li
    10. Tatsuya Suzuki
    11. Yumi Itoh
    12. Yuki Ozaki
    13. Shota Nakamura
    14. Satoaki Matoba
    15. Daron M Standley
    16. Toru Okamoto
    17. Junichi Takagi
    18. Atsushi Hoshino
    This article has 1 evaluations Latest evaluation on Dec 30, 2021 Published on Feb 22, 2022
  • Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening

    This article's authors
    1. Tomohisa Tanaka
    2. Akatsuki Saito
    3. Tatsuya Suzuki
    4. Yoichi Miyamoto
    5. Kazuo Takayama
    6. Toru Okamoto
    7. Kohji Moriishi
    This article has 1 evaluations Latest evaluation on Dec 30, 2021 Published on Dec 25, 2021
Previous Next
Stay updated. Get involved.
Subscribe to Mailing List
  • Blog
  • About Sciety
  • Contact
  • Follow us on Twitter
  • Follow us on Facebook
© 2022 eLife Sciences Publications Ltd. Legal information